Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (325 total)
-
Créateur: Coleman, Kristen K., Tham T. Nguyen, Su Yadana, Christophe Hansen-Estruch, William G. Lindsley, and Gregory C. Gray.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2018-11-30
Description: As a leading global city with a high population density, Singapore is at risk for the introduction of novel biological threats. -
Créateur: Lane, M. A., E. A. Brownsword, A. Babiker, J. M. Ingersoll, J. Waggoner, M. Ayers, M. Klopman, T. M. Uyeki, W. G. Lindsley, and C. S. Kraft.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-01-28
Description: Background: Previous research has shown that rooms of patients with COVID-19 present the potential for healthcare-associated transmission through aerosols containing SARS-CoV-2. However, data on the presence of these aerosols outside of patient rooms… -
Créateur: Blachere, Francoise M., William G. Lindsley, James E. Slaven, Brett J. Green, Stacey E. Anderson, Bean T. Chen, and Don H. Beezhold.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2007-05
Description: A Collison single-jet nebulizer was used to aerosolize the attenuated FluMist vaccine into a calm-air settling chamber. -
Créateur: Lane, M. A., E. A. Brownsword, J. S. Morgan, A. Babiker, S. A. Vanairsdale, G. M. Lyon, A. K. Mehta, J. M. Ingersoll, W. G. Lindsley, and C. S. Kraft.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-08-04
Description: Bioaerosol samples were collected in an airborne infection isolation room, bathroom and anteroom of a ventilated patient with coronavirus disease 2019. -
Créateur: Benenson, Shmuel, Yonatan Oster, Matan J. Cohen, and Ran Nir-Paz.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-23
Description: The surge of coronavirus disease 2019 (Covid-19) around the world and the need for urgent and intensive medical care have weighed heavily on health care systems and hospitals.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: Dagan, Noa, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A. Katz, Miguel A. Hernán, Marc Lipsitch, Ben Reis, and Ran D. Balicer.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-24
Description: As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting. In this study, data from Israel’s… -
Créateur: National Academies of Sciences, E. and Medicine
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2017-10-31
Description: During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to… -
Créateur: Chertow DS, Childs RW, Arai AE, Davey RT Jr.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2017-06-05
Description: In March, 2015, a 34 year-old previously healthy male healthcare worker was evacuated from Sierra Leone to the National Institutes of Health (NIH) Clinical Research Center for the management of severe Ebola virus disease (EVD). -
Créateur: Dean, Christina L., Jay W. Hooper, John M. Dye, Samantha E. Zak, Scott A. Koepsell, Laurence Corash, Richard J. Benjamin, Steve Kwilas, Shannon Bonds, Anne M. Winkler, and Colleen S. Kraft.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-03-04
Description: In 2014, passive immunization by transfusion of Ebola convalescent plasma (ECP) was considered for treating patients with acute Ebola virus disease (EVD).